Dr. Riedel is the Associate Medical Director of the Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center in Boston, MA, and he holds the academic rank of Associate Professor of Pathology at Harvard Medical School. From 2007 to 2016, Dr. Riedel was the Director of the Clinical Pathology Laboratories at Johns Hopkins Bayview Medical Center, with concomitant appointments as Assistant Professor of Pathology (2007-2014) and Associate Professor of Pathology (2014-2016) at The Johns Hopkins University, School of Medicine. From 2015-2016, he also held a secondary appointment as Associate Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He currently maintains appointments as an Adjunct Associate Professor of Pathology and Medicine at The Johns Hopkins University, School of Medicine.
Dr. Riedel’s research is focused on the diagnosis and management of sepsis as well as emerging antimicrobial resistance in gram-negative bacteria, including Neisseria gonorrhoeae, Enterobacteriacea, and non-fermentative bacteria such as Acinetobacter and Pseudomonas. He is particularly interested in surveillance programs for antimicrobial resistance, to enhance the understanding of emergence of antimicrobial resistance as well as the development of interventions to decrease the spread of resistance.
Dr. Riedel is a member of the following professional organizations: American Society for Microbiology (ASM), College of American Pathologists (CAP), and the American Society for Clinical Pathology (ASCP). He serves as a member of the CAP Microbiology Resource Committee, the Federal Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA), and as an advisor to the National Antimicrobial Susceptibility Testing Committee for the United States (USCAST). In addition, he serves as an associate editor for BMC Infectious Diseases and is member of the editorial board of the Journal of Clinical Microbiology.
Dr. Riedel received his M.D. and Ph.D. degrees in 1996 and 1999, respectively, from the Johann Wolfgang Goethe University in Frankfurt, Germany. After initial clinical training in general and orthopaedic surgery in England, Germany, and Switzerland, he completed residency training in anatomic and clinical pathology at Baylor University Medical Center in Dallas, TX, and a 2-year fellowship in medical and public health microbiology at the University of Iowa Hospitals & Clinics in Iowa City, IA. Dr. Riedel is board certified in Clinical Pathology and Medical Microbiology by the American Board of Pathology, and is a diplomate (active status) of the American Board of Medical Microbiology (ABMM).
This person is not in the org chart